A multidisciplinary Stibbe team advised Goed and its shareholders on its binding agreement with Mulitpharma relating to the sale of Goed’s pharmaceutical retail and wholesale business.
Stibbe advises the underwriters on the capital increase of Xior
Stibbe advised the underwriters on the successful capital increase of Xior by means of an accelerated bookbuilding (ABB), resulting in gross proceeds of EUR 75,7 million.